See more : Carnegie Wealth Management Nordiske Aktier (CMINOA.CO) Income Statement Analysis – Financial Results
Complete financial analysis of Ishihara Sangyo Kaisha,Ltd. (4028.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ishihara Sangyo Kaisha,Ltd., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Al Meera Consumer Goods Company Q.P.S.C. (MERS.QA) Income Statement Analysis – Financial Results
- Chr. Hansen Holding A/S (CHR.CO) Income Statement Analysis – Financial Results
- Park Hotels & Resorts Inc. (PK) Income Statement Analysis – Financial Results
- Lesaka Technologies, Inc. (UEPS) Income Statement Analysis – Financial Results
- The Hain Celestial Group, Inc. (0J2I.L) Income Statement Analysis – Financial Results
Ishihara Sangyo Kaisha,Ltd. (4028.T)
About Ishihara Sangyo Kaisha,Ltd.
Ishihara Sangyo Kaisha, Ltd. engages in the manufacture and sale of organic and inorganic chemicals in Japan, Asia, the United States, Europe, and internationally. The company offers titanium dioxide (TiO2) products under the TIPAQUE trade name, which includes white pigments for applications in paints, inks, plastics, paper, and other products; yellow pigments; and functional materials, such as ultrafine TiO2, ultrafine ZnO, electro-conductive materials, photocatalytic TiO2, high purity TiO2, titanium tetrachride, TiO2 for catalytic use, acicular type TiO2, glass coating, and battery materials. In addition, it offers matting agents; heat shield materials; agrochemicals, including herbicides, fungicides, insecticides, and nematicides; animal healthcare products; pharmaceutical reagents; and CF3-Pyridine organic intermediates for use in the pharmaceutical research. Ishihara Sangyo Kaisha, Ltd. was founded in 1920 and is headquartered in Osaka, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 138.46B | 131.24B | 110.96B | 101.77B | 101.07B | 106.44B | 108.00B | 101.60B | 102.90B | 103.33B | 105.29B | 100.44B | 102.38B | 99.06B | 104.51B | 104.66B | 117.28B | 106.16B | 104.37B | 96.52B |
| Cost of Revenue | 101.35B | 97.97B | 78.30B | 73.15B | 69.99B | 70.67B | 74.07B | 70.62B | 71.53B | 68.86B | 79.57B | 76.23B | 71.81B | 69.81B | 78.53B | 77.70B | 78.95B | 72.65B | 70.13B | 66.50B |
| Gross Profit | 37.10B | 33.27B | 32.66B | 28.62B | 31.08B | 35.77B | 33.93B | 30.98B | 31.37B | 34.48B | 25.73B | 24.22B | 30.57B | 29.25B | 25.98B | 26.96B | 38.33B | 33.51B | 34.23B | 30.02B |
| Gross Profit Ratio | 26.80% | 25.35% | 29.43% | 28.12% | 30.75% | 33.61% | 31.42% | 30.49% | 30.48% | 33.36% | 24.43% | 24.11% | 29.86% | 29.53% | 24.86% | 25.76% | 32.69% | 31.57% | 32.80% | 31.10% |
| Research & Development | 9.76B | 9.16B | 8.17B | 8.64B | 9.15B | 8.07B | 8.71B | 8.17B | 8.99B | 9.33B | 8.97B | 8.45B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 14.32B | 11.62B | 10.92B | 12.58B | 12.21B | 11.51B | 10.56B | 0.00 | 0.00 | 9.24B | 8.92B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 2.98B | 2.74B | 5.33B | 5.37B | 5.72B | 5.53B | 5.29B | 0.00 | 0.00 | 5.43B | 5.01B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 17.91B | 17.30B | 14.36B | 16.25B | 17.95B | 17.92B | 17.04B | 15.85B | 14.96B | 23.73B | 14.68B | 13.93B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | -2.06B | 276.00M | 185.00M | 198.00M | -29.00M | 183.00M | -147.00M | -147.00M | 673.00M | -49.00M | -742.00M | -438.00M | -665.00M | -618.00M | -1.04B | -794.00M | -602.00M | -1.06B | -1.71B | -1.28B |
| Operating Expenses | 25.61B | 24.63B | 21.10B | 23.45B | 24.89B | 24.40B | 23.91B | 22.56B | 23.05B | 23.37B | 22.69B | 21.42B | 20.81B | 20.21B | 20.50B | 21.58B | 22.32B | 20.80B | 20.84B | 19.66B |
| Cost & Expenses | 126.97B | 122.61B | 99.40B | 96.60B | 94.88B | 95.07B | 97.98B | 93.19B | 94.59B | 92.22B | 102.25B | 97.65B | 92.62B | 90.02B | 99.03B | 99.28B | 101.27B | 93.45B | 90.98B | 86.15B |
| Interest Income | 191.00M | 40.00M | 16.00M | 26.00M | 56.00M | 49.00M | 35.00M | 30.00M | 32.00M | 42.00M | 53.00M | 54.00M | 61.00M | 23.00M | 20.00M | 161.00M | 243.00M | 163.00M | 95.00M | 70.00M |
| Interest Expense | 1.26B | 481.00M | 539.00M | 537.00M | 609.00M | 717.00M | 919.00M | 1.13B | 1.40B | 1.56B | 1.75B | 1.85B | 1.76B | 1.84B | 1.73B | 1.78B | 1.94B | 1.28B | 1.05B | 1.33B |
| Depreciation & Amortization | 5.31B | 5.33B | 4.65B | 5.05B | 4.86B | 4.63B | 4.64B | 4.66B | 5.35B | 5.56B | 6.04B | 5.79B | 5.69B | 5.71B | 5.47B | 5.28B | 5.02B | 5.47B | 5.68B | 4.94B |
| EBITDA | 15.45B | 13.97B | 16.21B | 10.68B | 11.05B | 16.00B | 14.66B | 13.08B | 18.79B | 18.57B | -2.40B | 10.56B | 14.13B | 15.20B | 7.36B | 9.83B | 12.20B | -63.00M | -15.44B | 12.51B |
| EBITDA Ratio | 11.16% | 12.32% | 19.11% | 10.88% | 10.69% | 15.49% | 12.94% | 12.86% | 13.67% | 18.28% | 10.21% | 11.12% | 15.10% | 13.84% | 9.44% | 9.54% | 17.20% | 16.78% | 17.39% | 14.95% |
| Operating Income | 11.49B | 8.63B | 11.56B | 5.17B | 6.19B | 11.37B | 10.02B | 8.42B | 8.31B | 11.10B | 3.04B | 2.79B | 9.76B | 9.04B | 5.48B | 5.38B | 16.01B | 12.71B | 13.39B | 10.36B |
| Operating Income Ratio | 8.30% | 6.58% | 10.42% | 5.08% | 6.12% | 10.68% | 9.28% | 8.28% | 8.08% | 10.75% | 2.89% | 2.78% | 9.53% | 9.12% | 5.24% | 5.14% | 13.65% | 11.97% | 12.83% | 10.73% |
| Total Other Income/Expenses | -1.98B | 868.00M | 1.53B | -1.24B | -2.09B | -1.14B | -5.11B | -4.00B | 4.04B | 343.00M | -13.23B | 135.00M | -3.08B | -1.39B | -5.32B | -2.60B | -10.77B | -19.52B | -35.56B | -4.11B |
| Income Before Tax | 9.51B | 9.50B | 13.09B | 3.94B | 4.10B | 10.23B | 4.92B | 5.75B | 12.35B | 11.45B | -10.19B | 2.93B | 6.68B | 7.65B | 162.00M | 2.78B | 5.24B | -6.81B | -22.16B | 6.25B |
| Income Before Tax Ratio | 6.87% | 7.24% | 11.80% | 3.87% | 4.05% | 9.61% | 4.55% | 5.66% | 12.01% | 11.08% | -9.68% | 2.91% | 6.53% | 7.72% | 0.16% | 2.66% | 4.47% | -6.42% | -21.24% | 6.48% |
| Income Tax Expense | 1.50B | 2.55B | 1.40B | 564.00M | 1.74B | 1.54B | 1.47B | 622.00M | 2.89B | 4.46B | -2.35B | 2.00B | 3.73B | 2.82B | 1.48B | 3.20B | 2.59B | -2.93B | -11.41B | 466.00M |
| Net Income | 7.99B | 6.95B | 11.69B | 3.37B | 2.36B | 8.68B | 3.44B | 5.13B | 9.46B | 6.98B | -7.84B | 925.00M | 2.95B | 4.85B | -1.32B | -422.00M | 2.64B | -3.94B | -10.77B | 5.75B |
| Net Income Ratio | 5.77% | 5.29% | 10.54% | 3.31% | 2.33% | 8.16% | 3.19% | 5.04% | 9.20% | 6.76% | -7.44% | 0.92% | 2.88% | 4.90% | -1.27% | -0.40% | 2.25% | -3.71% | -10.32% | 5.96% |
| EPS | 209.26 | 175.73 | 292.59 | 84.41 | 59.03 | 217.25 | 86.11 | 95.15 | 236.64 | 174.60 | -195.91 | 23.10 | 73.70 | 121.20 | -33.05 | -10.74 | 68.70 | -105.44 | -289.45 | 157.00 |
| EPS Diluted | 209.26 | 175.73 | 292.59 | 84.41 | 59.03 | 217.25 | 86.11 | 95.15 | 236.64 | 174.60 | -195.91 | 23.10 | 73.70 | 121.20 | -33.05 | -10.74 | 68.70 | -105.44 | -289.45 | 157.00 |
| Weighted Avg Shares Out | 38.17M | 39.53M | 39.95M | 39.96M | 39.96M | 39.97M | 39.97M | 39.98M | 39.98M | 38.99M | 40.00M | 40.01M | 40.01M | 40.02M | 40.03M | 39.30M | 38.45M | 37.32M | 37.22M | 36.27M |
| Weighted Avg Shares Out (Dil) | 38.17M | 39.53M | 39.95M | 39.96M | 39.96M | 39.97M | 39.97M | 39.98M | 39.98M | 38.99M | 40.00M | 40.01M | 40.01M | 40.02M | 40.03M | 39.30M | 38.45M | 37.32M | 37.22M | 36.27M |
Source: https://incomestatements.info
Category: Stock Reports